Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Volatiles refer to a category of chemical elements and compounds characterized by their low boiling points, which allow them to easily vaporize at room temperature. These substances can be found in various environments, particularly in industrial settings, where exposure may occur due to the use of certain chemicals. Elevated levels of volatiles in the human body can indicate potential workplace exposure to harmful substances. The specific sample utilized for testing and the methodology applied can differ based on the particular volatile compound being analyzed. For instance, testing may involve compounds such as phenol (carbolic acid), acetic anhydride, and various aromatic solvents including toluene, xylene, and benzene. Additionally, other volatiles like naphthalene, oxygenated volatiles, acetone, propylene glycol, creosols, and ether may also be assessed. Understanding the presence and concentration of these volatiles is crucial for evaluating potential health risks associated with exposure and for implementing appropriate safety measures in the workplace.
© Copyright 2026 Coding Ahead. All rights reserved.
Testing for volatiles is typically indicated in situations where there is a suspicion of exposure to harmful chemical substances, particularly in occupational settings. The following conditions may warrant such testing:
The procedure for testing volatiles involves several key steps to ensure accurate results. Each step is critical for the integrity of the sample and the reliability of the test outcomes.
Post-procedure care following volatile testing typically involves monitoring the individual for any symptoms that may arise as a result of exposure. Depending on the results of the testing, further medical evaluation or intervention may be necessary. Individuals with elevated levels of volatiles may require additional assessments to evaluate potential health impacts and to develop a management plan. It is also important to provide education on minimizing future exposure to harmful substances, particularly for those working in environments where such chemicals are present. Regular follow-up testing may be recommended to monitor changes in exposure levels over time.
| Short Descr | ASSAY OF VOLATILES | Medium Descr | ASSAY OF VOLATILES | Long Descr | Volatiles (eg, acetic anhydride, diethylether) | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GA | Waiver of liability statement issued as required by payer policy, individual case |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Changed | Description Changed |
| 2013-01-01 | Changed | Medium Descriptor changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.